Agena Bioscience releases Chip prep module to automate sample handling after PCR for MassARRAY System

NewsGuard 100/100 Score

Agena Bioscience™ today introduced the Chip prep module to automate sample handling after PCR for the MassARRAY® 96-well System. This enables laboratories to operate the MassARRAY System largely unattended for high-throughput, multiplex genetic analysis.

"Whether you are a lab manager, pathologist, or medical director, automation of the post-PCR workflow reduces labor and helps to improve the quality and consistency of genetic testing. Laboratories can focus resources on the most impactful work," said Peter Dansky, Agena Bioscience's CEO. "The introduction of the Chip prep module demonstrates Agena Bioscience's ongoing commitment to help laboratories quickly and reliably translate genomic discoveries into clinical practice."

The Chip prep module is designed to minimize hands-on time and reduce the risk of cross contamination associated with manual sample handling. It automates several processing steps, including dispensing and desalting samples onto the SpectroCHIP® Array, and subsequently loading these onto the MassARRAY Analyzer.

High throughput laboratories can capitalize on the quick load-and-go process of the Chip prep module.

South Bend Medical Foundation, an early access site, has realized many of the benefits of the MassARRAY System in their clinical laboratory. "The flexibility to refine complicated testing methods quickly and easily has made the MassARRAY System an integral part of our molecular testing," said Dr. Bobbie Sutton, Pathologist and Director of Molecular Pathology.

"The addition of the Chip prep module simplifies our process and reduces the potential for contamination," added Tammy Ray, Medical Technologist for the laboratory.

The Chip prep module can process eight 96-pad SpectroCHIP Arrays in less than a day and it includes on-board cooling and storage, which allow overnight processing and storage of two additional SpectroCHIP Arrays. The module is an add-on to the MassARRAY Analyzer.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New genetic insights: Sugary beverages linked to higher risk of atrial fibrillation